Aerie Pharmaceuticals to commence clinical studies of dry eye treatment
The new drug was included in Aerie’s November 2019 acquisition of the Spanish company Avizorex Pharma, S.L., another ophthalmic pharmaceutical company specializing in dry eye disease treatment.
Read More
